Expand the pharyngitis paradigm for adolescents and young adults - PubMed

Expand the pharyngitis paradigm for adolescents and young adults

Robert M Centor. Ann Intern Med. 2009.

Abstract

Current guidelines and review articles emphasize that clinicians should consider group A beta-hemolytic streptococcus in the diagnosis and management of patients with acute pharyngitis. Recent data suggest that in adolescents and young adults (persons aged 15 to 24 years), Fusobacterium necrophorum causes endemic pharyngitis at a rate similar to that of group A beta-hemolytic streptococcus. On the basis of published epidemiologic data, F. necrophorum is estimated to cause the Lemierre syndrome-a life-threatening suppurative complication-at a higher incidence than that at which group A streptococcus causes acute rheumatic fever. Moreover, these estimates suggest greater morbidity and mortality from the Lemierre syndrome. The diagnostic paradigm for adolescent pharyngitis should therefore be expanded to consider F. necrophorum in addition to group A streptococcus. Expanding the pharyngitis paradigm will have several important implications. Further epidemiologic research is needed on both F. necrophorum pharyngitis (especially clinical presentation) and the Lemierre syndrome. Clinicians need reliable diagnostic techniques for F. necrophorum pharyngitis. In the meantime, adolescents and young adults who develop bacteremic symptoms should be aggressively treated with antibiotics for F. necrophorum infection. Physicians should avoid macrolides if they choose to treat streptococcus-negative pharyngitis empirically. Finally, pediatricians, internists, family physicians, and emergency department physicians should know the red flags for adolescent and young adult pharyngitis: worsening symptoms or neck swelling (especially unilateral neck swelling). Adolescent and young adult pharyngitis is more complicated than previously considered.

Comment in

• Should we expand the pharyngitis paradigm for adolescents and young adults?

  De Meyere EM, Matthys J. De Meyere EM, et al. Ann Intern Med. 2010 Apr 6;152(7):477-8; author reply 478. doi: 10.7326/0003-4819-152-7-201004060-00023. Ann Intern Med. 2010. PMID: 20368663 No abstract available.

Similar articles

• Should we expand the pharyngitis paradigm for adolescents and young adults?

  De Meyere EM, Matthys J. De Meyere EM, et al. Ann Intern Med. 2010 Apr 6;152(7):477-8; author reply 478. doi: 10.7326/0003-4819-152-7-201004060-00023. Ann Intern Med. 2010. PMID: 20368663 No abstract available.

• Fusobacterium necrophorum bacteremic tonsillitis: 2 Cases and a review of the literature.

  Centor RM, Geiger P, Waites KB. Centor RM, et al. Anaerobe. 2010 Dec;16(6):626-8. doi: 10.1016/j.anaerobe.2010.08.005. Epub 2010 Sep 8. Anaerobe. 2010. PMID: 20813196 Review.

• The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study.

  Centor RM, Atkinson TP, Ratliff AE, Xiao L, Crabb DM, Estrada CA, Faircloth MB, Oestreich L, Hatchett J, Khalife W, Waites KB. Centor RM, et al. Ann Intern Med. 2015 Feb 17;162(4):241-7. doi: 10.7326/M14-1305. Ann Intern Med. 2015. PMID: 25686164

• Adolescent pharyngitis: a review of bacterial causes.

  Mitchell MS, Sorrentino A, Centor RM. Mitchell MS, et al. Clin Pediatr (Phila). 2011 Dec;50(12):1091-5. doi: 10.1177/0009922811409571. Epub 2011 Jun 6. Clin Pediatr (Phila). 2011. PMID: 21646249 Review. No abstract available.

• Lemierre syndrome following oropharyngeal infection: a case series.

  Lu MD, Vasavada Z, Tanner C. Lu MD, et al. J Am Board Fam Med. 2009 Jan-Feb;22(1):79-83. doi: 10.3122/jabfm.2009.01.070247. J Am Board Fam Med. 2009. PMID: 19124638

Cited by

• Peaks in online inquiries into pharyngitis-related symptoms correspond with annual incidence rates.

  Brkic FF, Besser G, Janik S, Gadenstaetter AJ, Parzefall T, Riss D, Liu DT. Brkic FF, et al. Eur Arch Otorhinolaryngol. 2021 May;278(5):1653-1660. doi: 10.1007/s00405-020-06362-4. Epub 2020 Sep 23. Eur Arch Otorhinolaryngol. 2021. PMID: 32968893 Free PMC article.

• Unusual neurological presentation of Fusobacterium necrophorum disease.

  Haddad N, Morris T, Dhillon R, Gibbon F. Haddad N, et al. BMJ Case Rep. 2016 Jan 12;2016:bcr2015210710. doi: 10.1136/bcr-2015-210710. BMJ Case Rep. 2016. PMID: 26759436 Free PMC article.

• Clinical characteristics of a large cohort of patients with positive culture of Fusobacterium necrophorum.

  Klasinc R, Lupyr K, Zeller I, Paula H, Makristathis A, Tuchmann F, Wrba T, Assadian O, Presterl E. Klasinc R, et al. GMS Infect Dis. 2018 Mar 7;6:Doc03. doi: 10.3205/id000038. eCollection 2018. GMS Infect Dis. 2018. PMID: 30671334 Free PMC article.

• Tonsillar colonisation of Fusobacterium necrophorum in patients subjected to tonsillectomy.

  Björk H, Bieber L, Hedin K, Sundqvist M. Björk H, et al. BMC Infect Dis. 2015 Jul 10;15:264. doi: 10.1186/s12879-015-0975-z. BMC Infect Dis. 2015. PMID: 26159432 Free PMC article.

• Prevalence of Fusobacterium necrophorum in Children Presenting with Pharyngitis.

  Van TT, Cox LM, Cox ME, Dien Bard J. Van TT, et al. J Clin Microbiol. 2017 Apr;55(4):1147-1153. doi: 10.1128/JCM.02174-16. Epub 2017 Jan 25. J Clin Microbiol. 2017. PMID: 28122872 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • H1 Connect

• Medical

  • MedlinePlus Health Information